María Jesús
Vázquez Villar
GlaxoSmithKline (Spain)
Madrid, EspañaPublicacións en colaboración con investigadores/as de GlaxoSmithKline (Spain) (9)
2019
-
Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target
Science, Vol. 365, Núm. 6456
2012
-
Kinetic considerations on the development of binding assays in single-addition mode: Application to the search for α2δ1 modulators
Journal of Biomolecular Screening, Vol. 17, Núm. 8, pp. 1041-1049
2011
-
High-yield production and characterization of biologically active GST-tagged human topoisomerase IIα protein in insect cells for the development of a high-throughput assay
Protein Expression and Purification, Vol. 76, Núm. 2, pp. 165-172
2008
-
Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β-ketoacyl reductase reaction
FEBS Journal, Vol. 275, Núm. 7, pp. 1556-1567
2006
-
Utilization of substrate-induced quenching for screening targets promoting NADH and NADPH consumption
Journal of Biomolecular Screening, Vol. 11, Núm. 1, pp. 75-81
2005
-
A new destruxin as inhibitor of vacuolar-type H+-ATPase of Saccharomyces cerevisiae
Chemistry and Biodiversity, Vol. 2, Núm. 1, pp. 123-130
2004
-
Novel sesquiterpenoids as tyrosine kinase inhibitors produced by Stachybotrys chortarum
Tetrahedron, Vol. 60, Núm. 10, pp. 2379-2385
2003
-
A Novel Ergot Alkaloid as a 5-HT1A Inhibitor Produced by Dicyma sp.
Journal of Medicinal Chemistry, Vol. 46, Núm. 24, pp. 5117-5120
-
Determination of phosphate in nanomolar range by an enzyme-coupling fluorescent method
Analytical Biochemistry, Vol. 320, Núm. 2, pp. 292-298